| Drug Name |
Meclofenamate sodium |
| Drug ID |
BADD_D01363 |
| Description |
A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis. |
| Indications and Usage |
For the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
M01AG04; M02AA18 |
| DrugBank ID |
DB00939
|
| KEGG ID |
D00169
|
| MeSH ID |
D008469
|
| PubChem ID |
4038
|
| TTD Drug ID |
D08IFL
|
| NDC Product Code |
0378-2150; 38779-0237; 63126-301; 22568-1018; 49452-4397; 0378-3000 |
| Synonyms |
Meclofenamic Acid | Meclofenamate Sodium Anhydrous | Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, monosodium salt, monohydrate | Meclofenamate Sodium | Sodium Meclofenamate | Meclofenamate, Sodium | Meclofenamate Sodium Monohydrate | Meclofenamate | Meclomen |
